Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy

Fertility and Sterility

Volumn 92, Issue 1, 2009, Pages 197-204

  Persad, Carol C ^a   Zubieta, Jon Kar ^a,b   Love, Tiffany ^a,b   Wang, Heng ^a,b   Tkaczyk, Anne ^c   Smith, Yolanda R ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Brain; estrogen; functional MRI; hormones; menopause; neuroimaging; progestin; verbal memory; women's health

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; FEMHRT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; CEREBELLUM VERMIS; CINGULATE GYRUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; INSULA; NORMAL HUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; VERBAL MEMORY;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EDUCATIONAL STATUS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ETHINYL ESTRADIOL; FEMALE; HUMANS; JUDGMENT; LANGUAGE; MAGNETIC RESONANCE IMAGING; MEMORY; MENTAL STATUS SCHEDULE; MIDDLE AGED; NORETHINDRONE; PHONETICS; PLACEBOS; POSTMENOPAUSE; SPEECH;

EID: 67649106000     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.04.040     Document Type: Article

References (42)

1. Jacobs D.M., Tang M.X., Stern Y., Sano M., Marder K., Bell K.L., et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50 (1998) 368-373
2. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 29 (1995) 312-321
3. Resnick S.M., Metter E.J., and Zonderman A.B. Estrogen replacement therapy and longitudinal decline in visual memory. Neurology 49 (1997) 1491-1497
4. Smith Y.R., Minoshima S., Kuhl D.E., and Zubieta J.K. Effects of long-term hormone replacement therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endo Metab 86 (2001) 679-684
5. Matthews K., Cauley J., Yaffe K., and Zmuda J.M. Estrogen replacement therapy and cognitive decline in older community women. JAGS 47 (1999) 518-523
6. Low L., and Anstey K.J. Hormone replacement therapy and cognitive performance in postmenopausal women-a review by cognitive domain. Neurosci Biobehav Rev 30 (2006) 66-84
7. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91 (2006) 1802-1810
8. Shughrue P.J., and Merchenthaler I. Estrogen is more than just a 'sex hormone': novel sites for estrogen action in the hippocampus and cerebral cortex. Front Neuroendocrinol 21 (2000) 95-101
9. McEwen B.S., Alves S.E., Bulloch K., and Weiland N.G. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48 Suppl 7 (1997) S8-S15
10. Gazzaley A., and D'Esposito M. Unifying prefrontal cortex function: executive control, neural networks, and top-down modulation. In: Miller B.L., and Cummings J.L. (Eds). The human frontal lobes: functions and disorders (2007), The Guildford Press, New York 187-206
11. Smith E.E., and Jonides J. Storage and executive processes in the frontal lobes. Science 283 (1999) 1657-1661
12. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48 (2000) 854-860
13. Greene R.A. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Womens Med 45 (2000) 253-257
14. Slopien R., Junik R., Meczekalski B., Halerz-Nowakowska B., Maciejewska M., Watenik-Szymankiewicz A., et al. Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas 46 (2003) 253-257
15. Gleason C.E., Cholerton B., Carlsson C.M., Johnson S.C., and Asthana S. Neuroprotective effects of female sex steroids in humans: current controversies and future directions. Cell Mol Life Sci 62 (2005) 299-312
16. Nilsen J., Mor G., and Naftolin F. Estrogen regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligan system. J Neurobiol 43 (2000) 64-78
17. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
18. Resnick S.M., Maki P.M., Goloski S., Kraut M.A., and Zonderman A.B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 34 (1998) 171-182
19. Kugaya A., Epperson C.N., Zoghbi S., van Dyck C.H., Hou Y., Fujita M., et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160 (2003) 1522-1524
20. Shaywitz S.E., Shaywitz B.A., Pugh K.R., Fulbright R.K., Skudlarski P., Mencl W.E., et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281 (1999) 1197-1202
21. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 13 (2006) 411-422
22. Smith Y.R., Love T., Persad C.C., Tkaczyk A., Nichols T.E., and Zubieta J. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J Clin Endocrinol Metab 91 (2006) 4476-4481
23. Benedict R.H.B., Schretlen D., Groninger L., and Brandt J. Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist 12 (1998) 43-55
24. Yesavage J.A., Rose T.L., and Lapp D. Validity of the Geriatric Depression Scale in subjects with senile dementia (1981), Clinical Diagnostic and Rehabilitation Unit, Veterans Administration Medical Center, Palo Alto, CA
25. Wagner A.D., Schacter D.L., Rotte M., Koutstaal W., Maril A., Dale A.M., et al. Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science 281 (1998) 1188-1191
26. Noll D.C., Stenger V.A., Vazquez A.L., and Peltier S.J. Spiral scanning in functional MRI. In: Moonen C.T.W., and Bandettini P.A. (Eds). Medical radiology: functional MRI (1999), Springer-Verlag, Heidelberg 149-169
27. Acquirre G.K., and D'Esposito M. Experimental design for brain fMRI. In: Moonen C.T.W., and Bandettini P.A. (Eds). Medical radiology: functional MRI (1999), Springer-Verlag, Heidelberg 369-380
28. Friston K.J.K., Ashburner J., Frith C.D., Poline J.B., Heather J.D., and Frackowiak R.S.J. Spatial registration and normalization of images. Hum Brain Mapp 2 (1995) 165-189
29. Friston K.J., Frith C.D., Liddle P.F., and Frackowiak R.S.J. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metag 11 (1991) 690-699
30. Friston K.J., Worsley K.J., Frackowiak R.S.J., Mazziotta J.C., and Evans A.C. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1 (1994) 210-220
31. Fletcher P.C., Stephenson C.M.E., Carpenter T.A., Donovan T., and Bullmore E.T. Regional brain activations predicting subsequent memory success: an event-related fMRI study of the influence of encoding tasks. Cortex 39 (2003) 1009-1026
32. Otten L.J., Henson R.N., and Rugg M.D. Depth of processing effects on neural correlates of memory encoding. Relationship between findings from across- and within-task comparisons. Brain 124 (2001) 399-412
33. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulated cortex. Trends Cogn Sci 4 (2000) 215-222
34. Grady C.L., Springer M.V., Hongwanishkul D., McIntosh A.R., and Winocur G. Age-related changes in brain activity across the adult lifespan. J Cog Neurosci 18 (2006) 227-241
35. Reuter-Lorenz P.A., and Lustig C. Brain aging: reorganizing discoveries about the aging mind. Curr Opin Neurobiol 15 (2005) 245-251
36. Lacreuse A., Wilson M.E., and Herndon J.G. Estradiol, but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. Neurobiol Aging 23 (2002) 589-600
37. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 21 (2000) 107-116
38. Kipp M., Karakaya S., Pawlak J., Araujo-Wright G., Arnold S., and Beyer C. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors. Front Neuroendocrinol 27 (2006) 376-390
39. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
40. Bagger Y.Z., Tanko L.B., Alexandersen P., Qin G., and Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12 (2005) 12-17
41. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 138 (2006) 1027-1030
42. MacLennon A.H., Henderson V.W., Paine B.J., Ramsay E.N., Ryan P., Stocks N.P., et al. Hormone therapy, timing of initiation and cognition in women aged older than 60 years; the REMEMBER pilot study. Menopause 13 (2006) 28-36